Abstract
Immunocytochemical staining with monoclonal antibody NCRC 11 of formalin fixed paraffin embedded tumour tissue has been studied in 444 cases of primary breast cancer with a minimum follow period of 6 years. The relationship between extent of staining, assessed on a four point scale, and patient survival has been confirmed. There are significant relationships between staining and both histological grade and oestrogen receptor status. No association has been shown between staining and lymph node stage or tumour size. Simplification of staining assessment by modification to two staining groups still allows significant separation of patients into prognostic groups and incorporation into an existing prognostic index.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ellis, I., Bell, J., Todd, J. et al. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma. Br J Cancer 56, 295–299 (1987). https://doi.org/10.1038/bjc.1987.192
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.192
This article is cited by
-
Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer
British Journal of Cancer (2014)
-
Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer
Modern Pathology (2005)
-
Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein
Modern Pathology (2004)
-
The Nottingham prognostic index in primary breast cancer
Breast Cancer Research and Treatment (1992)
-
Cellular effects of tamoxifen in primary breast cancer
Breast Cancer Research and Treatment (1991)